Antibody Discovery

We specialize in generating hybridomas through immunization, constructing phage display libraries, and isolating antigen-specific single B cells to clone and express single-chain fragment variables (scFv) for the development of naturally or randomly paired antibodies. Our expertise lies in producing antagonistic or agonistic mono- or multi-specific therapeutic antibodies, particularly for applications in immuno-oncology, autoimmune disorders, and infectious diseas.